Last reviewed · How we verify

NCT06114849

Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 3)

Terminated NA Last updated 13 August 2025
What this trial tests

NA trial testing Treatment as usual in Suicide in 29 participants. Terminated before completion.

Timeline
20 November 2023
Primary endpoint
14 March 2025
14 March 2025

Quick facts

Lead sponsorHarvard University
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment29
Start date20 November 2023
Primary completion14 March 2025
Estimated completion14 March 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Harvard University

Who can join

18 and older, any sex, with Suicide or Distress, Emotional. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial is part of a series of brief interventions to reduce suicide risk in collaboration with the social media platform RallyPoint, a site specifically designed for U.S. servicemembers and veterans to connect with one another. In this RCT (Intervention 3: Professional Outreach), the investigators will test a psychoeducational intervention aimed at increasing users' likelihood of reaching out to mental health resources (e.g., suicide hotline) when experiencing distress.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Treatment as usual

Trials testing the same drug.

Other recruiting trials for Suicide

Currently open trials in the same condition.

Other Harvard University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06114849.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing